{
    "eid": "2-s2.0-85108324850",
    "title": "Population pharmacokinetics of oral levofloxacin in healthy volunteers and dosing optimization for multidrug-resistant tuberculosis therapy",
    "cover-date": "2021-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "levofloxacin",
        "Monte Carlo simulations",
        "multidrug-resistant tuberculosis",
        "pharmacodynamics",
        "population pharmacokinetics"
    ],
    "authors": [
        "Apinya Boonpeng",
        "Sutep Jaruratanasirikul",
        "Thitima Wattanavijitkul",
        "Monchana Nawakitrangsan",
        "Maseetoh Samaeng"
    ],
    "citedby-count": 1,
    "ref-count": 27,
    "ref-list": [
        "Limited sampling strategy and target attainment analysis for levofloxacin in patients with tuberculosis",
        "Diagnostic and prognostic value of serum albumin for tuberculosis in HIV infected patients eligible for antiretroviral therapy: Datafrom an HIV cohort study in India",
        "Population pharmacokinetics and pharmacodynamics of levofloxacin in acutely hospitalized older patients with various degrees of renal function",
        "Clinical relevance and management of drug-related QT interval prolongation",
        "Levofloxacin pharmacokinetics/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis",
        "The clinical pharmacokinetics of levofloxacin",
        "Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB",
        "Population pharmacokinetics and pharmacodynamics modeling of oral levofloxacin",
        "In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis",
        "Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis",
        "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG",
        "Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis",
        "Identifying 24 h variation in the pharmacokinetics of levofloxacin: A population pharmacokinetic approach",
        "Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis",
        "Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings",
        "Effects of three fluoroquinolones on QT interval in healthy adults after single doses",
        "Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis",
        "In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis",
        "Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases",
        "Population pharmacokinetic model and limited sampling strategies for personalized dosing of levofloxacin in tuberculosis patients",
        "Pharmacokinetics of levofloxacin in multidrug- and extensively drug-resistant tuberculosis patients",
        "Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: Results of a prospective multicenter study in China"
    ],
    "affiliation": [
        {
            "affiliation-city": "Phayao",
            "@id": "60114221",
            "affilname": "University of Phayao",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60114221",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Doctor Kasem Pangsrivongse Foundation",
        "Faculty of Medicine, Prince of Songkla University"
    ]
}